Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348946 · ClinicalTrials.gov registry record · Phase 2
Androgen Effect on Klinefelter Syndrome Motor Outcome
A Phase 2 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 2
- Development phase
- 93
- Enrollment target
NCT00348946 is a Phase 2 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 93 participants.
The verdict
NCT00348946, a Phase 2 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of low-dose androgen on the motor and cognitive development of boys with Klinefelter syndrome.
Interventions
- OTHER placebo
- DRUG androgen oxandrolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2006-07 |
| Est. Completion | 2017-11-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348946
The ClinicalTrials.gov registry entry for NCT00348946 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00348946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00348946 about?
NCT00348946 is a clinical study titled "Androgen Effect on Klinefelter Syndrome Motor Outcome". The purpose of this study is to evaluate the effects of low-dose androgen on the motor and cognitive development of boys with Klinefelter syndrome.
What is the current status of trial NCT00348946?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 93 participants. The study started on 2006-07. Estimated completion is 2017-11-30.
What interventions are being tested in trial NCT00348946?
The interventions under investigation include: placebo (OTHER), androgen oxandrolone (DRUG).
Who is sponsoring clinical trial NCT00348946?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.